Market News AIOpen the app

DataMEDS AI's Corexa Health has landed a deal to supply six peptides starting in November 2026.

DealRead the original at Benzinga
Good for MEDS

The agreement gives Corexa ingredient access for 6 peptides and supports its pharmacy and logistics plans. The drugs are not FDA-approved or evaluated for safety or effectiveness, but the supply deal advances a defined business plan.

MEDS · DataMEDS AI, Inc.

AI read · Good for MEDS

The AI's read

That gives Corexa a concrete step toward serving customers through its pharmacy network and logistics business. The company also plans to use its app to collect safety reports. But these compounded drugs are not FDA-approved or evaluated for safety or effectiveness, and dispensing has not started. The supply access still advances a business plan, so the news reads as favorable despite those limits.

Get alerts for MEDS

Follow DataMEDS AI, Inc. (MEDS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MEDS
Free on the App Store and Google Play, or on the web.